June 23, 2022
The state of Minnesota is adding two more COVID-19 test-to-treat sites: MSP Airport, beginning today (June 23), and Saint Paul-Midway, beginning on June 27.
At these sites, Minnesotans can get tested for COVID-19 and, if positive and determined to be high-risk, receive a prescription for medication at the same time.
The two sites join three federally supported community test-to-treat sites in Brooklyn Park, Moorhead, and Duluth. Since opening earlier this month, the sites have prescribed medication to more than 300 Minnesotans.
All of the community test-to-treat sites will continue to test Minnesotans at no cost. Minnesotans who test positive for COVID-19 via a rapid antigen test will be able to choose to be evaluated on site by a clinician and be given a prescription for the antiviral medication Paxlovid if it is deemed appropriate. Walk-ins are accepted, but appointments are recommended at mn.gov/covid19.
MDH and its testing partners are working with the Minnesota Board of Pharmacy to complete the steps necessary for dispensing medication on-site at test-to-treat locations. Until that is authorized, prescriptions are sent to either a pharmacy of a patient’s choosing or a nearby pharmacy to be filled.
The new community test-to-treat locations will join the existing 61 test-to-treat sites that are already operating statewide across Minnesota, mostly located at clinics or pharmacies with Minute Clinics. Minnesotans can find other test-to-treat sites using the federal government’s Test to Treat locator. Some sites may require appointments.
August 20, 2026
A physician and Olympian will give an inspirational address as part of this year's Empowering Physicians event on Friday, September 25, at the Minneapolis Institute of Art.
August 20, 2026
Minnesota received some disturbing news this week from the Centers for Disease Control and Prevention (CDC), as data shows that for the 2025-2026 school year, vaccination rates decreased and non-medical exemptions increased.
August 20, 2026
On August 11, a federal appellate court sided with the Texas Medical Association (TMA) argument that the way the No Surprises Act’s qualifying payment amount (QPA) is calculated has historically favored payers in arbitration.